AstraZeneca inks $555 million gene-editing technology deal with Algen, FT reports
AstraZeneca(US:AZN) Reutersยท2025-10-06 09:25Group 1 - AstraZeneca has signed a deal worth $555 million with Algen Biotechnologies, a biotech company based in San Francisco [1]